Genomic Tool Vendors Could Benefit From New International Rare-Disease Consortium

To support the International Rare Disease Research Consortium, or IRDiRC, the European Commission in July will launch a $140 million call for research proposals. Those familiar with the effort say sequencing- and array-based studies will be favored.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.